+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Acute Repetitive Seizures Market by Drug Type, Route Of Administration, Distribution Channel, End User, Age Group, Formulation - Global Forecast to 2030- Product Image
Acute Repetitive Seizures Market by Drug Type, Route Of Administration, Distribution Channel, End User, Age Group, Formulation - Global Forecast to 2030- Product Image
Sale

Acute Repetitive Seizures Market by Drug Type, Route Of Administration, Distribution Channel, End User, Age Group, Formulation - Global Forecast to 2030

  • PDF Icon

    Report

  • 192 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5888506
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Acute Repetitive Seizures Market is undergoing transformation as treatment modalities, patient management strategies, and regional regulations evolve. Forward-looking organizations require detailed market intelligence to navigate these complexities and drive effective business decisions.

Market Snapshot: Acute Repetitive Seizures Market Overview

The acute repetitive seizures market demonstrated measurable expansion, growing from USD 10.46 billion in 2024 to USD 11.66 billion in 2025, with expectations of reaching USD 19.48 billion by 2030 at a CAGR of 10.91%. This growth is supported by advancements in rescue therapies, sophisticated digital monitoring tools, and increased awareness among healthcare providers and patient communities. Innovations in care delivery, combined with favorable regulatory adjustments, are positioning both existing and emerging stakeholders to capture value across diverse patient populations.

Scope & Segmentation: Navigating Multiple Dimensions

This report analyzes the acute repetitive seizures market across essential segmentations to support precise decision-making. Stakeholders can assess opportunities throughout the following areas:

  • Drug Type: Branded options and generic alternatives serve varied demographic and economic needs.
  • Route of Administration: Available routes include buccal (midazolam), intramuscular (midazolam), intranasal (diazepam, midazolam), intravenous (diazepam, lorazepam), and rectal (diazepam) to accommodate clinical and at-home scenarios.
  • Distribution Channel: Hospital pharmacy, online pharmacy, and retail pharmacy pathways enable broad therapeutic reach and accessibility.
  • End User: Home care, hospitals, and specialty clinics offer differentiated contexts for rescue therapy initiation and support.
  • Age Group: Segments include adult, geriatric, and pediatric patients, each with unique requirements for dosing and administration.
  • Formulation: Auto-injector, nebulizer, and solution options align with advances in delivery science for fast and reliable intervention.
  • Geography: Regional insights address the Americas (including the U.S., Canada, Mexico, Brazil, Argentina), EMEA (United Kingdom, Germany, France, and key emerging markets), and Asia-Pacific (China, India, Japan, Australia, and others).
  • Technology Use: Digital monitoring, wearable detection devices, and telemedicine are shaping earlier intervention and patient engagement.

Key Takeaways for Senior Decision-Makers

  • Rapid shifts in diagnostic and therapeutic approaches are balancing intervention efficacy, patient safety, and ease of home administration to improve clinical outcomes.
  • Adoption of user-friendly intranasal, buccal, and auto-injector formulations is supporting increased patient and caregiver engagement outside hospital environments.
  • Collaboration among pharmaceutical companies, device manufacturers, and healthcare providers is enhancing integration of innovations into standard care pathways.
  • Rising generic competition is underpinning access in resource-constrained regions, with emphasis on affordable alternatives for underserved populations.
  • Changing regulatory climates are accelerating approvals for novel rescue therapies by emphasizing patient-centric outcomes and post-market evidence.
  • Regional disparities persist, with established payer and reimbursement models in the Americas and Western Europe contrasting with accessibility challenges in parts of EMEA and Asia-Pacific.

Impact of U.S. Tariff Adjustments

Forthcoming U.S. tariff changes in 2025 are expected to influence production costs, supply chains, and treatment access. Tariffs on imported raw materials and pharmaceutical components may necessitate supply chain adjustments, including regional manufacturing, procurement diversification, and strategic contract partnerships. Stakeholders focused on cost containment, pricing stability, and risk mitigation will be better positioned to maintain competitive advantage as the policy landscape evolves.

Methodology & Data Sources

This analysis draws on a mixed-method research framework, integrating qualitative interviews with neurologists, emergency medicine specialists, pharmacists, and patient representatives across major markets. Quantitative findings are synthesized from peer-reviewed literature, regulatory filings, clinical trial data, and proprietary sales figures. Data triangulation and expert validation ensure robust insight and market relevance.

Why This Report Matters

  • Enables organizations to benchmark against evolving standards in rescue therapy management and regional best practices.
  • Equips market leaders with actionable segmentation analytics and policy impact assessments to guide investment, portfolio, or partnership strategy.

Conclusion

The acute repetitive seizures market is shaped by expanding therapeutic options, regulatory adaptation, and increased demand for accessible, patient-friendly solutions. This report empowers senior leaders to align with market shifts and advance their organizational goals.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Acute Repetitive Seizures Market, by Drug Type
8.1. Introduction
8.2. Branded
8.3. Generic
9. Acute Repetitive Seizures Market, by Route Of Administration
9.1. Introduction
9.2. Buccal
9.2.1. Midazolam
9.3. Intramuscular
9.3.1. Midazolam
9.4. Intranasal
9.4.1. Diazepam
9.4.2. Midazolam
9.5. Intravenous
9.5.1. Diazepam
9.5.2. Lorazepam
9.6. Rectal
9.6.1. Diazepam
10. Acute Repetitive Seizures Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.4. Retail Pharmacy
11. Acute Repetitive Seizures Market, by End User
11.1. Introduction
11.2. Home Care
11.3. Hospitals
11.4. Specialty Clinics
12. Acute Repetitive Seizures Market, by Age Group
12.1. Introduction
12.2. Adult
12.3. Geriatric
12.4. Pediatric
13. Acute Repetitive Seizures Market, by Formulation
13.1. Introduction
13.2. Auto Injector
13.3. Nebulizer
13.4. Solution
14. Americas Acute Repetitive Seizures Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Acute Repetitive Seizures Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Acute Repetitive Seizures Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. UCB S.A.
17.3.2. Pfizer Inc.
17.3.3. Neurelis, Inc.
17.3.4. Aquestive Therapeutics, Inc.
17.3.5. Teva Pharmaceutical Industries Ltd.
17.3.6. Viatris Inc.
17.3.7. Sandoz International GmbH
17.3.8. Sun Pharmaceutical Industries Ltd.
17.3.9. Hikma Pharmaceuticals PLC
17.3.10. Mallinckrodt Pharmaceuticals
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. ACUTE REPETITIVE SEIZURES MARKET MULTI-CURRENCY
FIGURE 2. ACUTE REPETITIVE SEIZURES MARKET MULTI-LANGUAGE
FIGURE 3. ACUTE REPETITIVE SEIZURES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 18. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC ACUTE REPETITIVE SEIZURES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC ACUTE REPETITIVE SEIZURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ACUTE REPETITIVE SEIZURES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. ACUTE REPETITIVE SEIZURES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ACUTE REPETITIVE SEIZURES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BRANDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY MIDAZOLAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY MIDAZOLAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DIAZEPAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY MIDAZOLAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DIAZEPAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY LORAZEPAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DIAZEPAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AUTO INJECTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY SOLUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 67. CANADA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 68. CANADA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 69. CANADA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2030 (USD MILLION)
TABLE 70. CANADA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2030 (USD MILLION)
TABLE 71. CANADA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2030 (USD MILLION)
TABLE 72. CANADA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 73. CANADA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2030 (USD MILLION)
TABLE 74. CANADA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 75. CANADA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. CANADA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 77. CANADA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 78. MEXICO ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 79. MEXICO ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 80. MEXICO ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2030 (USD MILLION)
TABLE 81. MEXICO ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2030 (USD MILLION)
TABLE 82. MEXICO ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2030 (USD MILLION)
TABLE 83. MEXICO ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 84. MEXICO ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2030 (USD MILLION)
TABLE 85. MEXICO ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. MEXICO ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. MEXICO ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 88. MEXICO ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2030 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 124. UNITED KINGDOM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2030 (USD MILLION)
TABLE 126. UNITED KINGDOM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2030 (USD MILLION)
TABLE 128. UNITED KINGDOM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2030 (USD MILLION)
TABLE 130. UNITED KINGDOM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. UNITED KINGDOM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 134. GERMANY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 135. GERMANY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 136. GERMANY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2030 (USD MILLION)
TABLE 137. GERMANY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2030 (USD MILLION)
TABLE 138. GERMANY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2030 (USD MILLION)
TABLE 139. GERMANY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 140. GERMANY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2030 (USD MILLION)
TABLE 141. GERMANY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. GERMANY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. GERMANY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 144. GERMANY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 145. FRANCE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 146. FRANCE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 147. FRANCE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2030 (USD MILLION)
TABLE 148. FRANCE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2030 (USD MILLION)
TABLE 149. FRANCE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2030 (USD MILLION)
TABLE 150. FRANCE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 151. FRANCE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2030 (USD MILLION)
TABLE 152. FRANCE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. FRANCE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. FRANCE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 155. FRANCE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 166. RUSSIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 167. ITALY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 168. ITALY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 169. ITALY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2030 (USD MILLION)
TABLE 170. ITALY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2030 (USD MILLION)
TABLE 171. ITALY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2030 (USD MILLION)
TABLE 172. ITALY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 173. ITALY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2030 (USD MILLION)
TABLE 174. ITALY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. ITALY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. ITALY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 177. ITALY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 178. SPAIN ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 179. SPAIN ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 180. SPAIN ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2030 (USD MILLION)
TABLE 181. SPAIN ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2030 (USD MILLION)
TABLE 182. SPAIN ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2030 (USD MILLION)
TABLE 183. SPAIN ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 184. SPAIN ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2030 (USD MILLION)
TABLE 185. SPAIN ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. SPAIN ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. SPAIN ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 188. SPAIN ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2030 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2030 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2030 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 197. UNITED ARAB EMIRATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. UNITED ARAB EMIRATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 199. UNITED ARAB EMIRATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2030 (USD MILLION)
TABLE 204. SAUDI ARABIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 206. SAUDI ARABIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2030 (USD MILLION)
TABLE 207. SAUDI ARABIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. SAUDI ARABIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. SAUDI ARABIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 210. SAUDI ARABIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 212. SOUTH AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 213. SOUTH AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2030 (USD MILLION)
TABLE 214. SOUTH AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2030 (USD MILLION)
TABLE 215. SOUTH AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2030 (USD MILLION)
TABLE 216. SOUTH AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 217. SOUTH AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2030 (USD MILLION)
TABLE 218. SOUTH AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 219. SOUTH AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. SOUTH AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 221. SOUTH AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 222. DENMARK ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 223. DENMARK ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 224. DENMARK ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2030 (USD MILLION)
TABLE 225. DENMARK ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2030 (USD MILLION)
TABLE 226. DENMARK ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2030 (USD MILLION)
TABLE 227. DENMARK ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 228. DENMARK ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2030 (USD MILLION)
TABLE 229. DENMARK ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 230. DENMARK ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. DENMARK ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 232. DENMARK ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 233. NETHERLANDS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 234. NETHERLANDS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 235. NETHERLANDS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2030 (USD MILLION)
TABLE 236. NETHERLANDS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2030 (USD MILLION)
TABLE 237. NETHERLANDS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2030 (USD MILLION)
TABLE 238. NETHERLANDS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 239. NETHERLANDS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2030 (USD MILLION)
TABLE 240. NETHERLANDS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 241. NETHERLANDS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. NETHERLANDS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 243. NETHERLANDS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 244. QATAR ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 245. QATAR ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 246. QATAR ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2030 (USD MILLION)
TABLE 247. QATAR ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2030 (USD MILLION)
TABLE 248. QATAR ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2030 (USD MILLION)
TABLE 249. QATAR ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 250. QATAR ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2030 (USD MILLION)
TABLE 251. QATAR ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 252. QATAR ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. QATAR ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 254. QATAR ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 255. FINLAND ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 256. FINLAND ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 257. FINLAND ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2030 (USD MILLION)
TABLE 258. FINLAND ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2030 (USD MILLION)
TABLE 259. FINLAND ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2030 (USD MILLION)
TABLE 260. FINLAND ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 261. FINLAND ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2030 (USD MILLION)
TABLE 262. FINLAND ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 263. FINLAND ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. FINLAND ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 265. FINLAND ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 266. SWEDEN ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 267. SWEDEN ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 268. SWEDEN ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2030 (USD MILLION)
TABLE 269. SWEDEN ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2030 (USD MILLION)
TABLE 270. SWEDEN ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2030 (USD MILLION)
TABLE 271. SWEDEN ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 272. SWEDEN ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2030 (USD MILLION)
TABLE 273. SWEDEN ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 274. SWEDEN ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. SWEDEN ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 276. SWEDEN ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 277. NIGERIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 278. NIGERIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 279. NIGERIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2030 (USD MILLION)
TABLE 280. NIGERIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2030 (USD MILLION)
TABLE 281. NIGERIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2030 (USD MILLION)
TABLE 282. NIGERIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 283. NIGERIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2030 (USD MILLION)
TABLE 284. NIGERIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 285. NIGERIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 286. NIGERIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 287. NIGERIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 288. EGYPT ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 289. EGYPT ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 290. EGYPT ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2030 (USD MILLION)
TABLE 291. EGYPT ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2030 (USD MILLION)
TABLE 292. EGYPT ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2030 (USD MILLION)
TABLE 293. EGYPT ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 294. EGYPT ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2030 (USD MILLION)
TABLE 295. EGYPT ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 296. EGYPT ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 297. EGYPT ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 298. EGYPT ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 299. TURKEY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 300. TURKEY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 301. TURKEY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2030 (USD MILLION)
TABLE 302. TURKEY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2030 (USD MILLION)
TABLE 303. TURKEY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2030 (USD MILLION)
TABLE 304. TURKEY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 305. TURKEY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2030 (USD MILLION)
TABLE 306. TURKEY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 307. TURKEY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 308. TURKEY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 309. TURKEY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 310. ISRAEL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 311. ISRAEL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 312. ISRAEL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2030 (USD MILLION)
TABLE 313. ISRAEL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2030 (USD MILLION)
TABLE 314. ISRAEL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2030 (USD MILLION)
TABLE 315. ISRAEL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 316. ISRAEL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2030 (USD MILLION)
TABLE 317. ISRAEL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 318. ISRAEL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 319. ISRAEL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 320. ISRAEL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 321. NORWAY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 322. NORWAY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 323. NORWAY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2030 (USD MILLION)
TABLE 324. NORWAY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2030 (USD MILLION)
TABLE 325. NORWAY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2030 (USD MILLION)
TABLE 326. NORWAY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 327. NORWAY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2030 (USD MILLION)
TABLE 328. NORWAY ACUTE REPETITIVE SEIZURE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Acute Repetitive Seizures market report include:
  • UCB S.A.
  • Pfizer Inc.
  • Neurelis, Inc.
  • Aquestive Therapeutics, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Sandoz International GmbH
  • Sun Pharmaceutical Industries Ltd.
  • Hikma Pharmaceuticals PLC
  • Mallinckrodt Pharmaceuticals

Table Information

Report AttributeDetails
No. of Pages192
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 11.66 Billion
Forecasted Market Value ( USD ) by 2030 $ 19.48 Billion
Compound Annual Growth Rate10.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Acute Repetitive Seizures Market Size, Share & Trends Analysis Report By Product (USL-261, NRL-1, AZ-002, Diastat Rectal Gel), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) And Segment Forecasts, 2025 - 2030 - Product Image

Acute Repetitive Seizures Market Size, Share & Trends Analysis Report By Product (USL-261, NRL-1, AZ-002, Diastat Rectal Gel), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Acute Repetitive Seizures - Global Strategic Business Report - Product Image

Acute Repetitive Seizures - Global Strategic Business Report

  • Report
  • 180 Pages
  • Global
From
Seizures Pipeline Insight Analysis Report - Product Image

Seizures Pipeline Insight Analysis Report

  • Drug Pipelines
  • 150 Pages
  • Global
From
Epilepsy Drugs Market by Generation Type, Anti-Epileptics Drugs Type, Distribution Channel, and Region 2025-2033 - Product Image

Epilepsy Drugs Market by Generation Type, Anti-Epileptics Drugs Type, Distribution Channel, and Region 2025-2033

  • Report
  • 135 Pages
  • Global
From
Anticonvulsants Market by Drug Class, Indication, Route Of Administration, Distribution Channel, Formulation - Global Forecast to 2030 - Product Image

Anticonvulsants Market by Drug Class, Indication, Route Of Administration, Distribution Channel, Formulation - Global Forecast to 2030

  • Report
  • 191 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.